Stay updated on AK104 TACE Combo in Resectable HCC Clinical Trial
Sign up to get notified when there's something new on the AK104 TACE Combo in Resectable HCC Clinical Trial page.

Latest updates to the AK104 TACE Combo in Resectable HCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe history shows a new revision entry (v3.4.2) and deletion of the previous revision (v3.4.1); no study content, eligibility criteria, or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision entries were updated on the study record: v3.4.1 was added and v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page now includes a 'Show glossary' option and color-coded highlights to distinguish additions and deletions in the history view. The footer shows a revision change from v3.3.4 to v3.4.0 and removes the 'No FEAR Act Data' label.SummaryDifference1%

- Check39 days agoChange DetectedA new revision entry v3.3.4 was added to the Record History and the previous revision v3.3.3 was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedThe Record History now includes a new revision entry 'Revision: v3.3.3' and the footer text removes 'HHS Vulnerability Disclosure' along with the previous 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check89 days agoChange DetectedA new revision, v3.3.2, appears in the Record History, replacing the previous v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AK104 TACE Combo in Resectable HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 TACE Combo in Resectable HCC Clinical Trial page.